Ubs Group Ag Direxion Daily S&P Biotech Bea Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Ubs Group Ag holds 70 shares of LABD stock, worth $473. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 22,461
99.69%
Holding current value
$473
Previous $131,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LABD
# of Institutions
28Shares Held
2.45MCall Options Held
1.07MPut Options Held
144K-
Virtu Financial LLC New York, NY1.3MShares$8.79 Million0.5% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA511KShares$3.46 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.52 Million2.28% of portfolio
-
Jane Street Group, LLC New York, NY152KShares$1.03 Million0.0% of portfolio
-
Two Sigma Securities, LLC New York, NY61.2KShares$413,6640.06% of portfolio